Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen General Population Study
Sofie Bay Simony, Martin Bødtker Mortensen, Anne Langsted, et al.
Atherosclerosis (2022) Vol. 355, pp. 76-82
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society
Jeanine E. Roeters van Lennep, Lâle Tokgözoğlu, Lina Badimón, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4157-4173
Open Access | Times Cited: 95
Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment
Stamatios Lampsas, Maria Xenou, Evangelos Oikonomou, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 969-969
Open Access | Times Cited: 69
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society
Florian Kronenberg, Samia Mora, Erik S.G. Stroes, et al.
Atherosclerosis (2023) Vol. 374, pp. 107-120
Open Access | Times Cited: 61
Lipoprotein(a) and cardiovascular disease
Børge G. Nordestgaard, Anne Langsted
The Lancet (2024)
Closed Access | Times Cited: 27
Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels
Bożena Sosnowska, Janina Stępińska, Przemysław Mitkowski, et al.
Archives of Medical Science (2024) Vol. 20, Iss. 1, pp. 8-27
Open Access | Times Cited: 19
Lipoprotein(a) and cardiovascular disease: sifting the evidence to guide future research
Pia R. Kamstrup, R. Dermot G. Neely, Steven E. Nissen, et al.
European Journal of Preventive Cardiology (2024) Vol. 31, Iss. 7, pp. 903-914
Open Access | Times Cited: 10
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment
Anders Berg Wulff, Børge G. Nordestgaard, Anne Langsted
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 4, pp. 111-118
Closed Access | Times Cited: 10
The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
Sarah Zaman, Jason H. Wasfy, Vikas Kapil, et al.
The Lancet (2025)
Closed Access | Times Cited: 1
Lipoprotein(a) and calcific aortic valve disease initiation and progression: a systematic review and meta-analysis
Panteleimon Pantelidis, Evangelos Oikonomou, Stamatios Lampsas, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 8, pp. 1641-1655
Open Access | Times Cited: 17
Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study
Vera Bittner, Gregory G. Schwartz, Deepak L. Bhatt, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 4, pp. e548-e561
Open Access | Times Cited: 7
Lipoprotein(a) and cardiovascular disease
Michael B. Boffa, Marlys L. Koschinsky
Biochemical Journal (2024) Vol. 481, Iss. 19, pp. 1277-1296
Open Access | Times Cited: 7
Age-related Changes in the Adrenal Cortex: Insights and Implications
Kate Warde, Lorenzo J. Smith, Kaitlin J. Basham
Journal of the Endocrine Society (2023) Vol. 7, Iss. 9
Open Access | Times Cited: 16
Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population
Lijin Lin, Ke‐Qiong Deng, Ze Chen, et al.
Atherosclerosis (2023) Vol. 372, pp. 1-9
Open Access | Times Cited: 14
Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor
Marlys L. Koschinsky, Erik S.G. Stroes, Florian Kronenberg
Pharmacological Research (2023) Vol. 194, pp. 106843-106843
Open Access | Times Cited: 14
All we need to know about lipoprotein(a)
Courtney Bess, Anurag Mehta, Parag H. Joshi
Progress in Cardiovascular Diseases (2024)
Closed Access | Times Cited: 6
Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?
Georgios Tsioulos, Dimitris Kounatidis, Natalia G. Vallianou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3537-3537
Open Access | Times Cited: 5
Lipoprotein(a): Emerging insights and therapeutics
Gurleen Kaur, Khaled S. Abd‐Elrahman, Adam N. Berman, et al.
American Journal of Preventive Cardiology (2024) Vol. 18, pp. 100641-100641
Open Access | Times Cited: 5
Dietary n-3 alpha-linolenic and n-6 linoleic acids modestly lower serum lipoprotein(a) concentration but differentially influence other atherogenic lipoprotein traits: A randomized trial
Petrus Nuotio, Maria Lankinen, Topi Meuronen, et al.
Atherosclerosis (2024) Vol. 395, pp. 117562-117562
Open Access | Times Cited: 5
Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) Registry
Arthur Shiyovich, Adam N. Berman, Stephanie A. Besser, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 10
Open Access | Times Cited: 5
Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive Review
Jakub Michał Zimodro, M Mucha, Heiner K. Berthold, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 913-913
Open Access | Times Cited: 4
Intra-individual Variability in Lipoprotein(a) Levels: Findings from a Large Academic Health System Population
Kamal Awad, Ahmed Mahmoud, Mohammed Tiseer Abbas, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 4
Sex Differences of Lp(a) and Association With Mortality in a Primary Prevention Cohort
Tessa M Zeis, Danielle M. Brennan, Madlaina Costa‐Scharplatz, et al.
JACC Advances (2025) Vol. 4, Iss. 3, pp. 101596-101596
Open Access
Assessment of Cardiovascular Risk in Women: Progress so Far and Progress to Come
Lena Tschiderer, Lisa Seekircher, Peter Willeit, et al.
International Journal of Women s Health (2023) Vol. Volume 15, pp. 191-212
Open Access | Times Cited: 10
Lipoprotein(a) throughout life in women
Pablo Corral, María G. Matta, Carlos A. Aguilar‐Salinas, et al.
American Journal of Preventive Cardiology (2024) Vol. 20, pp. 100885-100885
Open Access | Times Cited: 3
Elevated lipoprotein(a) is independently associated with the presence of significant coronary stenosis in de-novo patients with stable chest pain
Gitte Stokvad Brix, Laust Dupont Rasmussen, Palle Duun Rohde, et al.
American Heart Journal (2025)
Closed Access
Page 1 - Next Page

Scroll to top